Monotherapy in patients with type 2 diabetes mellitus

被引:5
作者
Rhee, Sang Youl [1 ]
Kim, Hyun Jin [2 ]
Ko, Seung-Hyun [3 ]
Hur, Kyu Yeon [4 ]
Kim, Nan-Hee [5 ]
Moon, Min Kyong [6 ]
Park, Seok-O [7 ]
Lee, Byung-Wan [8 ]
Choi, Kyung Mook [5 ]
Kim, Jin Hwa [9 ]
机构
[1] Kyung Hee Univ, Sch Med, Dept Endocrinol & Metab, Seoul, South Korea
[2] Chungnam Natl Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Daejeon, South Korea
[3] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea
[4] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Internal Med, Seoul, South Korea
[5] Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea
[6] Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Div Endocrinol & Metab,Dept Internal Med, Seoul, South Korea
[7] Gwangmyeong Sungae Hosp, Dept Internal Med, Gwangmyeong, South Korea
[8] Yonsei Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea
[9] Chosun Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Gwangju, South Korea
关键词
Diabetes mellitus; type; 2; Hypoglycemic agents; Metformin; Practice guideline; DIPEPTIDYL PEPTIDASE-4 INHIBITORS; GLUCOSE-LOWERING EFFICACY; LONG-TERM METFORMIN; CARDIOVASCULAR OUTCOMES; PREVENTION PROGRAM; GLYCEMIC CONTROL; BLOOD-GLUCOSE; LIFE-STYLE; METAANALYSIS; EVENTS;
D O I
10.3904/kjim.2017.312
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In order to improve the quality of life and to prevent chronic complications related to diabetes mellitus, intensive lifestyle modification and proper medication are needed from the early stage of diagnosis of type 2 diabetes mellitus (T2DM). When using the first medication for diabetic patients, the appropriate treatment should be selected considering the clinical characteristics of the patient, efficacy of the drug, side effects, and cost. In general, the use of metformin as the first treatment for oral hypoglycemic monotherapy is recommended because of its excellent blood glu-cose-lowering effect, relatively low side effects, long-term proven safety, low risk of hypoglycemia, and low weight gain. If metformin is difficult to use as a first-line treatment, other appropriate medications should be selected in view of the clinical situation. If the goal of achieving glycemic control is not achieved by monotherapy, a combination therapy with different mechanisms of action should be initiated promptly.
引用
收藏
页码:959 / 966
页数:8
相关论文
共 54 条
  • [1] Cardiovascular and non-cardiovascular safety of dipeptidyl peptidase-4 inhibition: a meta-analysis of randomized controlled cardiovascular outcome trials
    Abbas, A. S.
    Dehbi, H. -M.
    Ray, K. K.
    [J]. DIABETES OBESITY & METABOLISM, 2016, 18 (03) : 295 - 299
  • [2] American Diabetes Association, 2017, Diabetes Care, V40, pS64
  • [3] Global Guideline for Type 2 Diabetes
    不详
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 104 (01) : 1 - 52
  • [4] Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study
    Aroda, Vanita R.
    Edelstein, Sharon L.
    Goldberg, Ronald B.
    Knowler, William C.
    Marcovina, Santica M.
    Orchard, Trevor J.
    Bray, George A.
    Schade, David S.
    Temprosa, Marinella G.
    White, Neil H.
    Crandall, Jill P.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (04) : 1754 - 1761
  • [5] Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations
    Bennett, Wendy L.
    Maruthur, Nisa M.
    Singh, Sonal
    Segal, Jodi B.
    Wilson, Lisa M.
    Chatterjee, Ranee
    Marinopoulos, Spyridon S.
    Puhan, Milo A.
    Ranasinghe, Padmini
    Block, Lauren
    Nicholson, Wanda K.
    Hutfless, Susan
    Bass, Eric B.
    Bolen, Shari
    [J]. ANNALS OF INTERNAL MEDICINE, 2011, 154 (09) : 602 - 613
  • [6] Meglitinide analogues for type 2 diabetes mellitus (Review)
    Black, C.
    Donnelly, P.
    McIntyre, L.
    Royle, P. L.
    Shepard, J. P.
    Thomas, S.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (02):
  • [7] Lower baseline glycemia reduces apparent oral agent glucose-lowering efficacy - A meta-regression analysis
    Bloomgarden, Zachary T.
    Dodis, Regina
    Viscoli, Catherine M.
    Holmboe, Eric S.
    Inzucchi, Silvio E.
    [J]. DIABETES CARE, 2006, 29 (09) : 2137 - 2139
  • [8] Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence
    Bonora, E
    Muggeo, M
    [J]. DIABETOLOGIA, 2001, 44 (12) : 2107 - 2114
  • [9] Borch-Johnsen K, 1999, LANCET, V354, P617
  • [10] Severe Hypoglycemia and Cardiovascular or All-Cause Mortality in Patients with Type 2 Diabetes
    Cha, Seon-Ah
    Yun, Jae-Seung
    Lim, Tae-Seok
    Hwang, Seawon
    Yim, Eun-Jung
    Song, Ki-Ho
    Yoo, Ki-Dong
    Park, Yong-Moon
    Ahn, Yu-Bae
    Ko, Seung-Hyun
    [J]. DIABETES & METABOLISM JOURNAL, 2016, 40 (03) : 202 - 210